Timken is expected to report Q1 earnings on April 24. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Timken's revenues will wane -18.1% and EPS will decrease -50.0%.
The average estimate for revenue is $1.16 billion. On the bottom line, the average EPS estimate is $0.79.
Last quarter, Timken tallied revenue of $1.08 billion. GAAP reported sales were 15% lower than the prior-year quarter's $1.26 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.80. GAAP EPS of $0.78 for Q4 were 30% lower than the prior-year quarter's $1.11 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 24.1%, 380 basis points worse than the prior-year quarter. Operating margin was 9.0%, 570 basis points worse than the prior-year quarter. Net margin was 7.0%, 160 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $4.77 billion. The average EPS estimate is $4.09.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 213 members out of 228 rating the stock outperform, and 15 members rating it underperform. Among 70 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 66 give Timken a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Timken is outperform, with an average price target of $52.00.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Timken to My Watchlist.
Copyright © 2009 The Motley Fool, LLC. All rights reserved.